Feasibility Study of a Medical Remote Patient Monitoring System in Hematology

Authors

J. Gay (1) ; S. Bernard (2) ; JB. Robin (1) ; K. Le Dû (3) ; A. Perrot (4) ; M. Autheman (5) ; A. Yazigi (5) ; C. Ferté (5) ; C. Araujo (6) ; S. Amorim (7) ; A. Morel (8)

‍

Affiliation

(1) Hématologie, C .H. de la C ôte Basque, Bayonne; (2) Hématologie, C H de la côte basque, Bayonne; (3) Hématologie, Hôpital Privé du Confluent, Nantes; (4) Hématologie, Oncopole, Toulouse; (5) Industriel, Resilience, Paris; (6) Hématologie, Clinique Belharra - Ramsay Santé, Bayonne; (7) Hématologie et thérapie cellulaire, Hôpital Saint Vincent de Paul, Lille; (8) Hématologie, Hôpital privé d'Antony - Ramsay Santé, Antony

‍

Introduction

Medical remote monitoring via electronic Patient-Reported Outcomes (ePROs) offers a unique opportunity to detect symptoms encountered by patients undergoing anti-cancer treatment early and enables proactive management.

Remote monitoring in oncology has demonstrated its effectiveness in reducing morbidity and improving quality of life through several Phase III randomized trials. Consequently, the European Society for Medical Oncology (ESMO) has recommended its use in routine clinical practice since 2022. However, the implementation and level of adherence of patients and healthcare providers to medical remote monitoring in onco-hematology remain underexplored.